Partial Seizures With Secondary Generalization

Also known as: Mixed seizure / Focal onset to bilateral tonic-clonic seizure / Partial seizures with secondary generalisation

Drug	Drug Name	Drug Description
DB00564	Carbamazepine	An anticonvulsant used to treat various types of seizures and pain resulting from trigeminal neuralgia.

Drug	Drug Name	Target	Type
DB00564	Carbamazepine	Voltage-gated sodium channel alpha subunit	target
DB00564	Carbamazepine	Cytochrome P450 2C8	enzyme
DB00564	Carbamazepine	Cytochrome P450 2B6	enzyme
DB00564	Carbamazepine	Cytochrome P450 3A4	enzyme
DB00564	Carbamazepine	Cytochrome P450 1A2	enzyme
DB00564	Carbamazepine	Cytochrome P450 2C19	enzyme
DB00564	Carbamazepine	Cytochrome P450 2C9	enzyme
DB00564	Carbamazepine	P-glycoprotein 1	transporter
DB00564	Carbamazepine	Cytochrome P450 3A5	enzyme
DB00564	Carbamazepine	UDP-glucuronosyltransferase 2B7	enzyme
DB00564	Carbamazepine	RalA-binding protein 1	transporter
DB00564	Carbamazepine	Canalicular multispecific organic anion transporter 1	transporter
DB00564	Carbamazepine	Neuronal acetylcholine receptor subunit alpha-4	target
DB00564	Carbamazepine	Nuclear receptor subfamily 1 group I member 2	target
DB00564	Carbamazepine	UDP-glucuronosyltransferase 1-1	enzyme
DB00564	Carbamazepine	UDP-glucuronosyltransferase 1-6	enzyme
DB00564	Carbamazepine	UDP-glucuronosyltransferase 1-7	enzyme

Drug	Drug Name	Phase	Status	Count